Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch

There are limited data on the safety and efficacy of switching to secukinumab from cyclosporine A (CyA) in patients with psoriasis. The purpose of the present study was to assess the efficacy and safety of secukinumab for 16 weeks after direct switching from CyA in patients with moderate‐to‐severe p...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Dermatol
Prif Awduron: Ohtsuki, Mamitaro, Morita, Akimichi, Igarashi, Atsuyuki, Imafuku, Shinichi, Tada, Yayoi, Fujita, Hiroyuki, Fujishige, Ayako, Yamaguchi, Masako, Teshima, Rie, Tani, Yumiko, Nakagawa, Hidemi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2017
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655923/
https://ncbi.nlm.nih.gov/pubmed/28543617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1346-8138.13911
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg